Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials.
Gridelli C, Morabito A, Gebbia V, Mencoboni M, Carrozza F, Viganò MG, Verusio C, Bollina R, Mattioli R, Valerio MR, Valmadre G, Maione P, Rossi A, Cascone T, Morgillo F, Di Maio M, Piccirillo MC, Gallo C, Perrone F, Ciardiello F. Gridelli C, et al. Among authors: maione p. Lung Cancer. 2010 Jan;67(1):86-92. doi: 10.1016/j.lungcan.2009.03.021. Lung Cancer. 2010. PMID: 19380175 Clinical Trial.
Carboplatin + epirubicin +VP-16 + lenograstim followed by radiotherapy + carboplatin as radiosensitizer in limited small cell lung cancer. A multicenter phase II study.
Gridelli C, Curcio C, Iaffaioli RV, Brancaccio L, D'Aprile M, Gebbia V, Rossi A, Tortoriello A, Veltri E, Maione P, Barbarisi A, Gallo C, Guida C, Perrone F. Gridelli C, et al. Among authors: maione p. Anticancer Res. 2001 Nov-Dec;21(6A):4179-83. Anticancer Res. 2001. PMID: 11911315 Clinical Trial.
Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II study.
Gridelli C, Rossi A, Barletta E, Panza N, Brancaccio L, Cioffi R, Pedicini T, Ianniello GP, Piazza E, Rossi N, Iaffaioli RV, Maione P, Di Maio M, Gallo C, Perrone F. Gridelli C, et al. Among authors: maione p. Lung Cancer. 2002 Jun;36(3):327-32. doi: 10.1016/s0169-5002(02)00003-x. Lung Cancer. 2002. PMID: 12009246 Clinical Trial.
Oral cytotoxic drugs.
Gridelli C, Rossi A, Guerriero C, Nicolella D, Ferrara C, Del Gaizo F, Colantuoni G, Airoma G, Maione P. Gridelli C, et al. Among authors: maione p. Suppl Tumori. 2002 Jul-Aug;1(4):S19-23. Suppl Tumori. 2002. PMID: 12415809 Review. No abstract available.
157 results